HB 2194 Missouri House · 2026 Regular Session

Modifies provisions relating to epinephrine delivery devices

HB 2194 allows students with asthma or anaphylaxis to self-administer prescribed epinephrine devices in school after meeting specific requirements. Schools must authorize this only if a physician approves a treatment plan, the student demonstrates proper skill, and parents sign a liability waiver acknowledging no school liability for non-negligent self-administration. The bill also permits trained school staff to use epinephrine devices during emergencies without civil liability, following established protocols. It requires schools to maintain emergency medication access and report all epinephrine use to emergency health providers. The law directly affects students with chronic conditions, schools, and school staff managing health emergencies.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2025
Committee Review
Floor Vote
Governor
Introduced Dec 5, 2025 Last action Feb 5, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
8
Key actions
2
Committee
3
Feb 5, 2026
Lower · Passed
HCS Reported Do Pass (H) - AYES: 17 NOES: 0 PRESENT: 0
lower
Feb 5, 2026
Lower · Passed
HCS Voted Do Pass (H)
lower
Jan 8, 2026
Committee
Referred: Health and Mental Health(H)
lower
Dec 5, 2025
Introduced
Prefiled (H)
lower
1 primary · 1 co-sponsor

Sponsors